Notable positive changes in fundamentals have recently occurred for Sarepta Therapeutics Inc (NASDAQ: SRPT): the consensus estimate for December, 2026 increased significantly, significant quarterly sales acceleration occurred, and significant quarterly earnings acceleration occurred.
Significant positive changes in investment behavior have recently occurred for Sarepta Therapeutics Inc (NASDAQ: SRPT): positive upside/downside volume developed.
In light of these very positive signals we are reviewing our current Overall Rating of C. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
Sarepta Therapeutics has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Sarepta Therapeutics has a very high Appreciation Score of 94 but a very low Power Rating of 1, producing the Neutral Value Trend Rating.
Recent Price Action
Sarepta Therapeutics Inc (NASDAQ: SRPT) stock enjoyed a large increase of 3.6% on 9/26/25. The stock closed at $18.36. However, this advance was accompanied by exceptionally low trading volume at 34% of normal. Relative to the market the stock has been extremely weak over the last nine months and has declined -0.9% during the last week.
Be the first to comment